Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (5 ops.)
Latest filing published 14 Feb 2023 for Comera Life Sciences Holdings, Inc., €7,879.
Filing timeline
BuySaleBarbara K. Finck
Insider track record
Disclosed buys
1
Disclosed sells
5
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -97.3%Entry US$1.33 · Close at T+365 US$0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Barbara K. Finck: trading record in brief
Barbara K. Finck is a declared insider at 2 companies; the most frequent names are Coherus Oncology, Inc. and Comera Life Sciences Holdings, Inc. In total, 13 filings cover trades dated from 15 December 2017 to 4 January 2023.
The open-market side counts 1 purchase for €7,879 alongside 5 sales for €103k. Sales outweigh purchases by €95k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 5 option exercises. 2023 to date brings 1 purchase and no sales.
The newest entry dates from 14 February 2023: an open-market purchase of €7,879, in Comera Life Sciences Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Barbara K. Finck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,756 shares@ US$1.23100.0% of flowCommon StockSEC:0001062993-23-003497:0
Canonical exit: 4 Apr 2023 (T+90)
6,756 shares@ €1.166250.0% of flowCommon StockSEC:0001062993-23-000611:0
1,760 shares@ US$1.421.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-024270:0
1,760 shares@ US$18.5825.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-024270:1
1,760 shares@ US$1.422.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-022461:0
1,760 shares@ US$19.0226.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-022461:1
500 shares@ US$1.420.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-019736:0
500 shares@ US$15.035.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-019736:1
1,260 shares@ US$1.421.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-019736:2
1,260 shares@ US$15.0014.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-019736:3
1,760 shares@ US$1.421.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-017372:0
1,760 shares@ US$15.0020.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-017372:1
7,545 shares0Common Stock, $0.0001 par valueSEC:0000899243-17-029152:0
13 of 13 declarations
